Hyloris Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.5%.

Top 13 shareholders own 59.11% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
36.44%	Stijn Van Rompay	10,202,034	€125.5m	0%	no data
13.06%	Thomas Jacobsen	3,657,505	€45.0m	0%	no data
6.17%	Bart Versluys	1,727,623	€21.2m	0%	no data
2.94%	Saffelberg Nv	824,061	€10.1m	0%	no data
0.15%	Mandarine Gestion	42,500	€522.7k	-29.17%	0.03%
0.1%	Degroof Petercam Asset Management	28,975	€356.4k	0%	no data
0.086%	Aramea Asset Management AG	24,127	€296.8k	0%	0.06%
0.071%	Dietmar Aichhorn	20,000	€246.0k	0%	no data
0.062%	Koenraad Van Der Elst	17,443	€214.6k	0%	no data
0.011%	Jean-Luc Vandebroek	3,000	€36.9k	0%	no data
0.0071%	Claresco Finance	2,000	€24.6k	0%	0.01%
0.0027%	Dimensional Fund Advisors LP	766	€9.4k	-0.13%	no data
0.0011%	State Street Global Advisors, Inc.	303	€3.7k	-15.13%	no data